Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Atropine_sulfate
|
| gptkbp:contraindication |
gptkb:sneaker
gptkb:Insurance_Company urinary retention prostatic hypertrophy |
| gptkbp:form |
injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Atropen
|
| gptkbp:ingredients |
atropine
|
| gptkbp:is_used_for |
treatment of organophosphate poisoning
|
| gptkbp:legal_issue |
prescription only
|
| gptkbp:manager |
intramuscular injection
|
| gptkbp:manufacturer |
Various manufacturers
|
| gptkbp:side_effect |
dizziness
nausea dry mouth blurred vision |